Menu

Topics

Connect

Comments

Want to discuss? Please read our Commenting Policy first.

Canada invests millions more in domestic drug development to combat COVID-19

WATCH: Montreal facility to produce Novavax vaccine in the fight against COVID-19 – Feb 2, 2021

The federal government is investing millions of new dollars to boost Canada’s domestic vaccine and drug development capacity.

Story continues below advertisement

Innovation Minister Francois-Philippe Champagne says Canada must build and expand homegrown biomanufacturing facilities and develop more equipment to secure more vaccines and therapeutics to combat COVID-19.

Ottawa will contribute up to $54.2 million to KABS Laboratories and up to $13.44 million to Immune Biosolutions to expand their respective operations in Quebec.

It will also provide up to $32.7 million to Novocol Pharmeceutical of Canada for growth of its biomanufacturing facilities in Ontario.

Ottawa is also investing $150 million to help companies advance through the early stages of research and development of several Canadian-made vaccine candidates.

Advertisement
Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article